ArticleFrontiers in microbiology2017
Differential Growth of
Open access · goldAbstract read
In one paragraph
Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 24 citations in OpenAlex.
- Characterization of carABpyrB operon and role of pyrE in Francisella novicida biofilm.MicrobiologyOpen · 2026Article
- Structure of the hibernating Francisella tularensis ribosome and mechanistic insights into its inhibition by antibiotics.Nucleic acids research · 2026Article
- Animal modelling with theMicrobiology (Reading, England) · 2025Article
- Virulence and genome analysis of three historicalFrontiers in cellular and infection microbiology · 2025Article
- Treatment of bacterial biothreat agents with a novel purified bioactive lactoferrin affects both growth and biofilm formation.Frontiers in cellular and infection microbiology · 2025Article
- Mutation ofMicrobiology (Reading, England) · 2024Article
- Diverse roles of low-molecular weight thiol GSH inCurrent research in microbial sciences · 2024Article
- Development and Properties ofVaccines · 2022Article
- Why vary what's working? Phase variation and biofilm formation inFrontiers in microbiology · 2022Review
- Arginine Catabolism and Polyamine Biosynthesis Pathway Disparities WithinFrontiers in microbiology · 2022Article
- Early infection-induced natural antibody response.Scientific reports · 2021Article
- Phase Variation of LPS and Capsule Is Responsible for Stochastic Biofilm Formation inFrontiers in cellular and infection microbiology · 2021Article
- Development, Phenotypic Characterization and Genomic Analysis of aFrontiers in microbiology · 2021Article
- Virulence ofMicroorganisms · 2020Article
- The Sensor Kinase QseC Regulates the Unlinked PmrA Response Regulator and Downstream Gene Expression inJournal of bacteriology · 2020Article
- The Francisella tularensis Polysaccharides: What Is the Real Capsule?Microbiology and molecular biology reviews : MMBR · 2020Review
- Autotransporter-Mediated Display of Complement Receptor Ligands by Gram-Negative Bacteria Increases Antibody Responses and Limits Disease Severity.Pathogens (Basel, Switzerland) · 2020Article
- Development, Characterization, and Standardization of a Nose-Only Inhalation Exposure System for Exposure of Rabbits to Small-Particle Aerosols Containing Francisella tularensis.Infection and immunity · 2019Article
- Article
- Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.PloS one · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 7 institutions in 1 country.
Kristen M HollandDepartment of Immunology and Microbial Disease, Albany Medical CollegeAlbany, NY, United States.
Sarah J RosaDepartment of Immunology and Microbial Disease, Albany Medical CollegeAlbany, NY, United States.
Kolbrun KristjansdottirDepartment of Biomedical Sciences, Midwestern UniversityDowners Grove, IL, United States.
Donald WolfgeherDepartment of Molecular Genetics and Cell Biology, University of ChicagoChicago, IL, United States.
Brian J FranzDepartment of Immunology and Microbial Disease, Albany Medical CollegeAlbany, NY, United States.
Tiffany M ZarrellaDepartment of Immunology and Microbial Disease, Albany Medical CollegeAlbany, NY, United States.
Sudeep KumarDepartment of Immunology and Microbial Disease, Albany Medical CollegeAlbany, NY, United States.
Raju SunagarDepartment of Immunology and Microbial Disease, Albany Medical CollegeAlbany, NY, United States.
Anju SinghTrudeau InstituteSaranac Lake, NY, United States.
Chandra S BakshiDepartment of Microbiology and Immunology, New York Medical CollegeValhalla, NY, United States.
Prachi NamjoshiDepartment of Immunology and Microbial Disease, Albany Medical CollegeAlbany, NY, United States.
Eileen M BarrySchool of Medicine, University of MarylandBaltimore, MD, United States.
Timothy J SellatiTrudeau InstituteSaranac Lake, NY, United States.
Stephen J KronDepartment of Molecular Genetics and Cell Biology, University of ChicagoChicago, IL, United States.
Edmund J GosselinDepartment of Immunology and Microbial Disease, Albany Medical CollegeAlbany, NY, United States.
Douglas S ReedCenter for Vaccine Research, University of PittsburghPittsburgh, PA, United States.
Karsten R O HazlettDepartment of Immunology and Microbial Disease, Albany Medical CollegeAlbany, NY, United States.
Albany Medical Center Hospital · USTrudeau Institute · USUniversity of Chicago · USMidwestern University · USNew York Medical College · USUniversity of Maryland, Baltimore · USUniversity of Pittsburgh · US
Funding
TLR2/NLR Signal Regulation of Protective Immunity to F. TularensisP01AI056320 · NIAID · ALBANY MEDICAL COLLEGE · PI METZGER, DENNIS W · 2003 to 2016
$22.9MCorrelates of Vaccine-Induced, Tunable-Protection in an Outbred Tularemia ModelR01AI123129 · NIAID · ALBANY MEDICAL COLLEGE · PI BARRY, EILEEN M., HAZLETT, KARSTEN R.O. · 2016 to 2020
$3.7MCriteria-Directed Vaccine Generation Via Ag Mimicry, Adjuvancy, And APC-TargetingR01AI100138 · NIAID · ALBANY MEDICAL COLLEGE · PI GOSSELIN, EDMUND J, HAZLETT, KARSTEN R.O. · 2013 to 2017
$2.9MAdvancement of a Defined, Protective, Live Attenuated Tularemia VaccineR01AI102966 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BARRY, EILEEN M. · 2013 to 2015
$2.1MAdvancement of New Live Attenuated F. Tularensis Type A Vaccine StrainsU01AI077909 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BARRY, EILEEN M. · 2009 to 2010
$1.1MNIAID NIH HHS P01 AI056320NIAID NIH HHS R01 AI100138NIAID NIH HHS R01 AI102966NIAID NIH HHS R01 AI123129NIAID NIH HHS U01 AI077909
Abstract
The gram-negative bacterium
Indexed as
bacterial adaptationbacterial capsulesbacterial mediatularemia immunizationvirulence factor
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.